Nutritional and medical therapy for dyslipidemia in patients with cardiovascular disease.

P. Logan, Sean Clarke

Research output: Contribution to journalReview article

Abstract

Dyslipidemia is a significant risk factor for the progression of cardiovascular disease, particularly when associated with other risk factors. An understanding of the pathophysiology and risks for patients with atherosclerotic diseases of undertreated dyslipidemia is essential for the healthcare provider. In this article, a review of epidemiologic data regarding the role of lipid levels in cardiovascular disease prognosis is presented. A familiarity with current dietary and drug treatment of lipid disorders is at the core of an evidence-based approach to dyslipidemia management in the patient with established cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)40-52
Number of pages13
JournalAACN clinical issues
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint

Dyslipidemias
Cardiovascular Diseases
Lipids
Health Personnel
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Leadership and Management
  • Care Planning
  • Advanced and Specialized Nursing

Cite this

Nutritional and medical therapy for dyslipidemia in patients with cardiovascular disease. / Logan, P.; Clarke, Sean.

In: AACN clinical issues, Vol. 12, No. 1, 01.01.2001, p. 40-52.

Research output: Contribution to journalReview article

@article{a16f9e6ed8e34cea964a11e6d3de307d,
title = "Nutritional and medical therapy for dyslipidemia in patients with cardiovascular disease.",
abstract = "Dyslipidemia is a significant risk factor for the progression of cardiovascular disease, particularly when associated with other risk factors. An understanding of the pathophysiology and risks for patients with atherosclerotic diseases of undertreated dyslipidemia is essential for the healthcare provider. In this article, a review of epidemiologic data regarding the role of lipid levels in cardiovascular disease prognosis is presented. A familiarity with current dietary and drug treatment of lipid disorders is at the core of an evidence-based approach to dyslipidemia management in the patient with established cardiovascular diseases.",
author = "P. Logan and Sean Clarke",
year = "2001",
month = "1",
day = "1",
doi = "10.1097/00044067-200102000-00006",
language = "English (US)",
volume = "12",
pages = "40--52",
journal = "AACN Advanced Critical Care",
issn = "1559-7768",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Nutritional and medical therapy for dyslipidemia in patients with cardiovascular disease.

AU - Logan, P.

AU - Clarke, Sean

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Dyslipidemia is a significant risk factor for the progression of cardiovascular disease, particularly when associated with other risk factors. An understanding of the pathophysiology and risks for patients with atherosclerotic diseases of undertreated dyslipidemia is essential for the healthcare provider. In this article, a review of epidemiologic data regarding the role of lipid levels in cardiovascular disease prognosis is presented. A familiarity with current dietary and drug treatment of lipid disorders is at the core of an evidence-based approach to dyslipidemia management in the patient with established cardiovascular diseases.

AB - Dyslipidemia is a significant risk factor for the progression of cardiovascular disease, particularly when associated with other risk factors. An understanding of the pathophysiology and risks for patients with atherosclerotic diseases of undertreated dyslipidemia is essential for the healthcare provider. In this article, a review of epidemiologic data regarding the role of lipid levels in cardiovascular disease prognosis is presented. A familiarity with current dietary and drug treatment of lipid disorders is at the core of an evidence-based approach to dyslipidemia management in the patient with established cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=0035260938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035260938&partnerID=8YFLogxK

U2 - 10.1097/00044067-200102000-00006

DO - 10.1097/00044067-200102000-00006

M3 - Review article

C2 - 11288327

AN - SCOPUS:0035260938

VL - 12

SP - 40

EP - 52

JO - AACN Advanced Critical Care

JF - AACN Advanced Critical Care

SN - 1559-7768

IS - 1

ER -